Physician profile
Terry Blais Compton
NPI 1720508534
$1,497.12
in general payments reported to CMS, 2019-2025
9 companies · $249 in 2025
The $249 reported for 2025 was more than what 87% of Diabetes Educator providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $259 · 2022: $398 · 2023: $191 · 2024: $400 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $456.05 | 2022-2025 | Freestyle Libre, Freestyle Libre 3 |
| Dexcom, INC. | $419.69 | 2021-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $407.53 | 2021-2025 | Rybelsus, Ozempic |
| Beta Bionics, INC. | $120.96 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Sequel Med Tech, LLC | $26.33 | 2025 | Twiist |
| Sanofi-Aventis U.S. LLC | $21.06 | 2022 | |
| Embecta Corp. | $17.00 | 2024 | Bd Autoshield Duo |
| Xeris Pharmaceuticals, INC. | $15.49 | 2023 | Gvoke Hypopen |
| Lifescan, INC. | $13.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Compton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.